Seouleaguer Co., Ltd. Stock

Equities

A043710

KR7043710003

Drug Retailers

End-of-day quote Korea S.E. 18:00:00 2024-04-28 EDT 5-day change 1st Jan Change
545 KRW +1.30% Intraday chart for Seouleaguer Co., Ltd. -0.18% -26.25%

Financials

Sales 2022 10.11B 7.36M 10.05M Sales 2023 22.56B 16.42M 22.42M Capitalization 37.1B 27.01M 36.87M
Net income 2022 -6.38B -4.65M -6.35M Net income 2023 -3.3B -2.4M -3.28M EV / Sales 2022 2.5 x
Net cash position 2022 7.91B 5.76M 7.87M Net Debt 2023 3.96B 2.88M 3.94M EV / Sales 2023 1.82 x
P/E ratio 2022
-5.28 x
P/E ratio 2023
-11.2 x
Employees 7
Yield 2022 *
-
Yield 2023
-
Free-Float 48.57%
More Fundamentals * Assessed data
Dynamic Chart
SEOULEAGUER Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
SEOULEAGUER Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
SEOULEAGUER Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
SEOULEAGUER Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
SEOULEAGUER Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Seouleaguer Co., Ltd. announced that it has received KRW 9.9999998 billion in funding from Sesim Co., Ltd. CI
Seouleaguer Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Seouleaguer Co., Ltd. announced that it has received KRW 9.9999998 billion in funding from Sesim Co., Ltd. CI
Seouleaguer Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Seouleaguer Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Seouleaguer Co., Ltd. announced that it expects to receive KRW 9.9999998 billion in funding from Sesim Co., Ltd. CI
Seouleaguer Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Seouleaguer Co., Ltd. cancelled the acqusition of 50% stake in Look Optics Co., Ltd. From Neoplux No.1 Private Equity Fund, managed by Neoplux Co., Ltd. CI
Seouleaguer Co., Ltd. announced that it has received KRW 5 billion in funding CI
Seouleaguer Co., Ltd. announced that it expects to receive KRW 5 billion in funding CI
More news
1 day+1.30%
1 week-0.18%
Current month-12.52%
1 month-12.52%
3 months-18.17%
6 months-18.66%
Current year-26.25%
More quotes
1 week
531.00
Extreme 531
583.00
1 month
531.00
Extreme 531
637.00
Current year
531.00
Extreme 531
763.00
1 year
531.00
Extreme 531
1 062.00
3 years
531.00
Extreme 531
2 045.00
5 years
531.00
Extreme 531
3 200.00
10 years
531.00
Extreme 531
14 500.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 -
Comptroller/Controller/Auditor 44 -
Members of the board TitleAgeSince
Director/Board Member 50 18-10-18
Chief Executive Officer 54 -
Director/Board Member 48 -
More insiders
Date Price Change Volume
24-04-28 545 +1.30% 38 818
24-04-26 538 -3.06% 25,247
24-04-25 555 +0.18% 22,351
24-04-24 554 0.00% 12,048
24-04-23 554 +0.36% 24,938

End-of-day quote Korea S.E., April 28, 2024

More quotes
SEOULEAGUER CO., LTD, formerly ROCKETMOBILE CO., LTD, is a Korea-based company principally engaged in the drug sales business. The Company operates its business through four segments. The Healthcare Business segment distributes medicines and cosmetics. The Management Service Organization (MSO) Business segment involves in the advertising and real estate lease business. The Medical Business segment provides medical services such as skin care. The Mobile Accessory segment offers mobile accessories and peripherals including cases, cradles, chargers, bluetooth and others.
More about the company
  1. Stock Market
  2. Equities
  3. A043710 Stock